Alyatec
Presentation of clinical results in AAAAI congress
The results of the clinical study conducted by ALYAT...
Read more
Become volunteer
You can take part in medical research improvements
Conclusion of a Clinical Study for Regeneron Pharmaceuticals
ALYATEC is pleased and proud to announce the completion of a clinical study conducted for the American company Regeneron Pharmaceuticals.
This study started in February 2019 and completed in May 2020 aimed to evaluate the efficacy of a drug candidate for asthmatic patients allergic to cat.
